Allscripts (MDRX) PT Raised to $13 at Cantor Fitzgerald Following In-Line 4Q Results

February 17, 2017 7:22 AM

Cantor Fitzgerald analyst Steven Halper reiterates Neutral rating and raises price target on Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found